| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c50a5858a106895c7c9f6459d67b93ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 |
| filingDate |
2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18159fc833c9435fd03fd3975b5bae90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6ac9ba4b94dc2ef266efc0b8e053cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c9dd0beffa1f590bb8e43e399535ea4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2bd1afb2fe55c69cead7d0eb3a6884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a307f2e6593ba5ca894a8d0ef665cf0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_702bc1ec76053c99e28cc9abbcd6f9b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_887c0a272495520a066319d8a27fd0fc |
| publicationDate |
2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MY-153032-A |
| titleOfInvention |
Curcumin compounds with superior structural stability and processes for their preparation thereof |
| abstract |
ACCORDINGLY, THE INVENTION DISCLOSES COMPOUNDS WITH ENHANCED BIOAVAILABILITY FOR THE PREVENTION AND TREATMENT OF ANTI-HUMAN IMMUNODEFICIENCY VIRUS (HIV), ANTI-TUBERCULOSIS (TB), ANTI-ALZHEIMER OR ANTI-CANCER. THE INVENTION ALSO DISCLOSES THE METHOD IN SYNTHESIZING THESE COMPOUNDS WHEREIN THE STEPS INCLUDES MIXING CURCUMIN, ISATIN DERIVATIVES OR NINHYDRIN AND PROLINE IN 20 ML METHANOL. THE MIXTURE WAS THEN REFLUXED WITH A SOLVENT ON A WATER BATH AND EXCESS SOLVENT WAS REMOVED UNDER VACUUM. THE RESIDUE SUBJECTED TO FLASH COLUMN CHROMATOGRAPHY USING PETROLEUM ETHER: ETHYL ACETATE MIXTURE (4:1) AS ELUENT TO AFFORD THE PRODUCT. THE RATIO FOR CURCUMIN: ISATIN DERIVATIVE/NINHYDRIN: PROLINE IS 1:1:2 AND 1:2:4. |
| priorityDate |
2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |